Expertise in
1
conditions

Dr. David S. Poch

Intensive Care Medicine
Office
9434 Medical Center Dr, 
La Jolla, CA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
1
conditions
Office
9434 Medical Center Dr, 
La Jolla, CA 

Overview

David Poch is an Intensive Care Medicine provider practicing medicine in La Jolla, California.

Dr. Poch is highly rated in 1 condition, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Angioplasty, and Splenectomy.

He is actively involved in clinical research, co-authoring 40 peer reviewed articles and participating in 7 clinical trials. Dr. Poch is currently accepting new patients.

Specialties

Intensive Care Medicine

Licenses

Internal Medicine in CA

Hospital Affiliations

Uc San Diego Health Hillcrest - Hillcrest Med Ctr

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
California Health And Wellness
  • MANAGED MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Inland Empire Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Office
9434 Medical Center Dr, La Jolla, CA 92037

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
Enrollment Status: Terminated
Publish Date: June 08, 2026
Intervention Type: Other, Drug
Study Drug: Sotatercept
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
Enrollment Status: Terminated
Publish Date: February 22, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
View 6 Less Clinical Trials

40 Total Publications

Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
Journal: Respirology (Carlton, Vic.)
Published: October 02, 2025
Similar Doctors
Expertise in
4
conditions
Dr. George Z. Cheng
Intensive Care Medicine
Expertise in
4
conditions
Dr. George Z. Cheng
Intensive Care Medicine
Referral may be required
Before you request

UCSD Heath Care

3855 Health Sciences Dr, 
La Jolla, CA 
 (0.2 miles away)
858-822-6100
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

George Cheng is an Intensive Care Medicine provider practicing medicine in La Jolla, California. He has been practicing medicine for over 17 years. Dr. Cheng is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Emphysema, Advanced Bronchoscopy, and Endoscopy. Dr. Cheng is currently accepting new patients.

Expertise in
2
conditions
Dr. Niral M. Patel
Intensive Care Medicine
Expertise in
2
conditions
Dr. Niral M. Patel
Intensive Care Medicine
Referral may be required
Before you request

UCSD Heath Care

3855 Health Sciences Dr, 
La Jolla, CA 
 (0.2 miles away)
858-822-6100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Niral Patel is an Intensive Care Medicine provider practicing medicine in La Jolla, California. Dr. Patel is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Emphysema, Advanced Bronchoscopy, and Endoscopy. Dr. Patel is currently accepting new patients.

Expertise in
1
conditions
Dr. Wael Z. El Maraachli
Intensive Care Medicine
Expertise in
1
conditions
Dr. Wael Z. El Maraachli
Intensive Care Medicine
Referral required
Before you request

Office

4520 Executive Dr, 
San Diego, CA 
 (0.9 miles away)
855-355-5864
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Wael El Maraachli is an Intensive Care Medicine provider practicing medicine in San Diego, California. Dr. El Maraachli is highly rated in 1 condition, according to our data. His clinical expertise encompasses Nontuberculous Mycobacterial Lung Disease, Lung Nodules, Pulmonary Fibrosis, Emphysema, and Gastrostomy. Dr. El Maraachli is currently accepting new patients.

Frequently Asked Questions about Dr. David S. Poch

How do I make an appointment with Dr. David S. Poch?

You can book an appointment with Dr. David S. Poch by calling their office at 858-657-7150. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David S. Poch a top-rated expert for Angioplasty?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David S. Poch is classified as an Advanced expert for Angioplasty, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David S. Poch specialize in?

While Dr. David S. Poch is a Intensive Care Medicine, they have specific expertise in Angioplasty, Splenectomy, and Systemic Sclerosis (SSc). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. David S. Poch participate in research or clinical trials?

Yes. Dr. David S. Poch has published 40 articles and abstracts on conditions like Angioplasty. You can view a list of Dr. David S. Poch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David S. Poch accept my insurance?

Dr. David S. Poch accepts most major insurance plans, including Anthem BCBS and Blue Shield of California. We recommend calling the office directly at 858-657-7150 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Poch's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile